You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
長藥控股(300391.SZ):目前在研品種為與大學合作研究的1.1類新藥葛厚石苓顆粒,用於預防、治療病毒性肺炎和感冒
格隆匯 06-20 09:08

格隆匯6月20日丨有投資者向長藥控股(300391.SZ)提問,“現在公司的定位是光伏還是汽車零部件還是藥企,還有就是公司研製的新藥什麼時候投放市場,能帶來多少盈利能力”

長藥控股回覆稱,公司主營業務包含醫藥製造業、新能源業,形成以醫藥製造業務為主,光伏設備業務並進發展的格局。目前公司在研品種為與大學合作研究的1.1類新藥葛厚石苓顆粒,用於預防、治療病毒性肺炎和感冒,已完成處方藥味及藥材資源評估、飲片炮製、製備工藝、成品質量、穩定性等研究,即將完成藥理毒理試驗。目前沒有上市銷售,短期內對業績沒有實質性影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account